tiprankstipranks
LSL Pharma Group Inc (TSE:LSL)
:LSL
Canadian Market

LSL Pharma Group Inc (LSL) Financial Statements

Compare
2 Followers

LSL Pharma Group Inc Financial Overview

LSL Pharma Group Inc's market cap is currently ―. The company's EPS TTM is C$-0.017; its P/E ratio is ―; LSL Pharma Group Inc is scheduled to report earnings on May 6, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Jul 22Dec 21Dec 20Sep 20
Income Statement
Total Revenue
Gross Profit$ 1.65M-$ 2.53M$ 943.03K$ 507.58K
Operating Income$ -6.67M$ -70.85K$ -65.27K$ 564.05K$ 809.27K
EBITDA$ -5.77M$ -70.85K$ 931.55K$ 747.58K$ 990.62K
Net Income$ -8.47M$ -74.22K$ -1.78M$ 152.47K$ 88.01K
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 30.90M$ 25.51K$ 29.03M$ 27.18M$ 23.79M
Total Debt$ 15.74M$ 0.00$ 12.74M$ 10.57M$ 10.57M
Net Debt$ 15.73M$ -288.00$ 12.00M$ 8.64M$ 10.11M
Total Liabilities$ 22.25M$ 285.47K$ 17.92M$ 16.84M$ 16.31M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -8.09M$ -3.21K$ -2.00M$ -1.12M$ -203.35K
Operating Cash Flow$ -7.07M$ -3.21K$ -1.08M$ -291.13K$ -117.85K
Investing Cash Flow
Financing Cash Flow
Currency in USD

LSL Pharma Group Inc Earnings and Revenue History

LSL Pharma Group Inc Debt to Assets

LSL Pharma Group Inc Cash Flow

LSL Pharma Group Inc Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis